81 related articles for article (PubMed ID: 18408429)
1. [Combined irinotecan (CPT-11) and nedaplatin (254-S) therapy for advanced and/or recurrent cervical cancer].
Hiruma R; Kamide T; Anzai N; Matsumoto R; Kotake Y; Wachi T; Shinozaki H; Tada A; Kamiya N; Sasaki H
Gan To Kagaku Ryoho; 2008 Apr; 35(4):607-10. PubMed ID: 18408429
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer.
Machida S; Ohwada M; Fujiwara H; Konno R; Takano M; Kita T; Kikuchi Y; Komiyama S; Mikami M; Suzuki M
Oncology; 2003; 65(2):102-7. PubMed ID: 12931014
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer.
Tsuda H; Hashiguchi Y; Nishimura S; Miyama M; Nakata S; Kawamura N; Negoro S
Br J Cancer; 2004 Sep; 91(6):1032-7. PubMed ID: 15292935
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy.
Takatori E; Shoji T; Miura Y; Takeuchi S; Yoshizaki A; Sugiyama T
J Obstet Gynaecol Res; 2013 Aug; 39(8):1354-8. PubMed ID: 23800356
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
Abou-Taleb HA; Koshiyama M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Abiko K; Yamanoi K; Murakami R; Horikawa N; Taha AA; Kitamura S; Konishi I
J Int Med Res; 2016 Apr; 44(2):346-56. PubMed ID: 26831404
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K
Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382
[TBL] [Abstract][Full Text] [Related]
8. Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.
Ohara T; Kobayashi Y; Yoshida A; Yoshioka N; Yahagi N; Kondo H; Tozawa A; Kiguchi K; Suzuki N
Int J Clin Oncol; 2013 Dec; 18(6):1102-6. PubMed ID: 23095879
[TBL] [Abstract][Full Text] [Related]
9. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
[TBL] [Abstract][Full Text] [Related]
10. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
11. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study.
Umesaki N; Fujii T; Nishimura R; Tanaka T; Nishida M; Fushiki H; Takizawa K; Yamamoto K; Hasegawa K; Izumi R;
Gynecol Oncol; 2004 Oct; 95(1):127-32. PubMed ID: 15385121
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study.
Yamamoto K; Kokawa K; Umesaki N; Nishimura R; Hasegawa K; Konishi I; Saji F; Nishida M; Noguchi H; Takizawa K
Oncol Rep; 2009 Apr; 21(4):1005-9. PubMed ID: 19288001
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Takekuma M; Hirashima Y; Ito K; Tsubamoto H; Tabata T; Arakawa A; Itani Y; Furukawa N; Murakoshi H; Takeuchi S
Gynecol Oncol; 2012 Sep; 126(3):341-5. PubMed ID: 22609108
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer.
Oshita F; Yamada K; Saito H; Noda K
Cancer Chemother Pharmacol; 2008 Aug; 62(3):465-70. PubMed ID: 17960380
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
[TBL] [Abstract][Full Text] [Related]
18. Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
Ohe M; Oshita F; Kenmotsu Y; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
J Exp Ther Oncol; 2012; 10(1):65-9. PubMed ID: 22946345
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
Oshita F; Yamada K; Kato Y; Ikehara M; Noda K; Tanaka G; Nomura I; Suzuki R; Saito H
Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]